Finzati - Logo
DWTX logo

Dogwood Therapeutics, Inc.

DWTX • Biotechnology
$2.29
▼ -0.05 (-2.14%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$66.59M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 2.76Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:02 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.29
Change-2.14%
Market Cap$66.59M
52W Range1.28 - 9.50
Beta1.76
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio2.76
Quick Ratio2.76
Volume21.99K

Investment DNA

How strong this company looks for long-term investors

48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 2.76Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 12/17/2020
Industry: Biotechnology
P/B i: 0.46
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.00
Current Ratio: 2.76
Quick Ratio: 2.76
Status: Good

Insider Transactions

Recent executive and insider activity

Keefer David R
Transaction: 06/16/2026
BUY
Change
+16,800
Price
$1.50
Filing
06/17/2026
Type
BUY
Whitley Richard James
Transaction: 06/16/2026
BUY
Change
+16,800
Price
$1.50
Filing
06/17/2026
Type
BUY
Thomas John C
Transaction: 06/16/2026
BUY
Change
+16,800
Price
$1.50
Filing
06/17/2026
Type
BUY